Pre-Emptive Use of Rituximab in Epstein–Barr Virus Reactivation: Incidence, Predictive Factors, Monitoring, and OutcomesApostolia Papalexandri, Ioanna Sakellari, Anna Vardi et al.|International Journal of Molecular Sciences|2023Cited by 6